AI-enhanced optical imaging to improve thyroid nodule diagnosis
Official title: Advancing Thyroid Cancer Diagnostics with AI-enhanced Multimodal Optical Histopathology
Funded at Methodist Hospital Research Institute · NIH-11251733 · Data updated 2026-11-12
This project uses advanced, label-free optical imaging plus AI to help doctors tell which thyroid nodules are harmless and which need treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | January 1, 2025 |
| Project end | December 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $488,056 |
| NIH project number | 5R01CA288613-02 |
| Project ID | NIH-11251733 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people with thyroid nodules, especially those who received indeterminate fine needle aspiration results or are deciding about biopsy or surgery.
✕Less likely to help
People without thyroid nodules or those whose diagnosis is already clear from standard tests are unlikely to benefit directly from this work.
What this research studies
You would have detailed, label-free images taken of your thyroid tissue using a special microscope that captures multiple light-based signals (for example, two-photon and Raman techniques) without chemical stains. An AI-powered computer will combine those different image types to help distinguish benign nodules from papillary thyroid carcinoma and detect features linked to lymph node spread. Researchers will compare the AI-guided imaging results to standard biopsy and pathology reports to see whether it can reduce unclear results, repeat procedures, or unnecessary surgery. Some parts of the work may require visits to Houston Methodist for imaging or sample collection.
Why it matters
Potential benefit: If successful, this approach could give faster, more accurate diagnoses and reduce unneeded biopsies or surgeries for people with thyroid nodules.
How similar studies have gone: Early lab and pilot studies combining label-free optical imaging and AI have shown promising accuracy, but wider clinical validation for thyroid nodules remains limited.
Where this research is happening
-
Methodist Hospital Research Institute
Houston, United States Active
Researchers
- Principal investigator: Wong, Stephen Tc — Methodist Hospital Research Institute
- Study coordinator: Wong, Stephen Tc
Related research
Other NIH-funded projects on the same topics.
-
WTC Dust and Thyroid Cancer Progression in Human Organoids
This grant tests how World Trade Center dust might influence thyroid cancer progression using human thyroid organoids to model real-life exposure.
-
Integrating molecular signals to guide thyroid cancer care
A doctor-scientist team at Brigham and Women’s Hospital is studying how tumor biology and the immune environment can guide personalized monitoring and treatment for differentiated thyroid cancer.
-
Metabolic Imaging to Track Treatment Response in Aggressive Thyroid Cancer
This grant explores a new way to watch how aggressive thyroid cancers respond to treatment using a special MRI technique that tracks tumor metabolism.
-
Adoptive T-cell Therapy for Anaplastic Thyroid Cancer
A patient-focused program explores using patient immune cells engineered to target and fight anaplastic thyroid cancer, especially for those whose cancer has stopped responding to standard treatments.
-
Overcoming Resistance to BRAF Inhibitors in Aggressive Thyroid Cancers
A patient-focused research effort to find new ways to treat difficult thyroid cancers that no longer respond to current BRAF inhibitors.
-
Improving Treatment of Anaplastic Thyroid Cancer with New Therapies and Early Response Checks
This NIH grant aims to advance treatment for a rare, aggressive thyroid cancer by testing new approaches and measuring how tumors respond early in treatment to tailor care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.